| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |